BCRX
BioCryst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.96
−1.29%Forward multiples
Based on analyst estimates
- P/E forward
- 19.21x
- P/E 2026E
- —
- P/E 2027E
- 17.16x
- P/E 2028E
- 13.80x
- P/S forward
- 3.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.60x
- Price / sales
- 2.71x
- Price / cash flow
- 7.07x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 2.77x
- EV / EBITDA
- -8.59x
- EV / EBIT
- -8.31x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026